|

The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery

RECRUITINGPhase 4Sponsored by King Abdullah International Medical Research Center
Actively Recruiting
PhasePhase 4
SponsorKing Abdullah International Medical Research Center
Started2025-07-15
Est. completion2027-06-24
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07089251

Summary

The aim of this clinical trial is to evaluate the effect of administering low-dose epinephrine and tranexamic acid on perioperative blood loss, thromboembolic complications, and hospitalization duration in patients undergoing knee joint arthroplasty. Also aim to evaluate the effect of administering low-dose epinephrine and tranexamic acid on perioperative thromboembolic complications, and hospitalization duration

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients undergoing knee joint arthroplasty.
* Saudi and Non-Saudi Patient.
* Patients who have Complete medical record.

Exclusion Criteria:

* End stage renal disease
* Liver cirrhosis
* Coagulopathy
* Pre-operative Hgb \<10 5.
* History of cerebrovascular accident or myocardial infarction in past 12 months.
* History of Heart failure.
* History of arrhythmia.
* History of pheochromocytoma, thyrotoxicosis and glaucoma.
* Pregnancy or breast feeding
* History of Deep venous thrombosis or pulmonary embolism
* Allergy to epinephrine or tranexamic acid

Conditions7

ArthritisBlood LossEpinephrineKnee Arthritis, OsteoarthritisKnee Arthroplasty, TotalTotal Knee AnthroplastyTranexamic Acid Use

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.